After decades of relying on treatments approved for other diseases, on January 15, 2021 the FDA approved the first drug for AL Amyloidosis. Truly a game-changing, monumental advancement in the treatment of this disease.
Macroglossia is the abnormal enlargement of the tongue in proportion to other structures in the mouth. It can be found in cases of both AL and ATTR amyloidosis. Read more about symptoms and treatment.
